Editing Scorpio Technology
The edit can be undone. Please check the comparison below to verify that this is what you want to do, and then publish the changes below to finish undoing the edit.
Latest revision | Your text | ||
Line 3: | Line 3: | ||
Scorpio Technology is a UK company, involved in the development and rollout of a new anti-viral, anti-bacterial air-purification technology for use in hospitals, care homes, schools and offices. Its technology avoids the use of HEPA filters and UV, together with their associated environmental and operational shortfalls. | Scorpio Technology is a UK company, involved in the development and rollout of a new anti-viral, anti-bacterial air-purification technology for use in hospitals, care homes, schools and offices. Its technology avoids the use of HEPA filters and UV, together with their associated environmental and operational shortfalls. | ||
<vimeo> | <html> | ||
<iframe width="560" height="315" src="https://player.vimeo.com/video/682932410?h=5df088484e" frameborder="0" allow="accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture" allowfullscreen></iframe> | |||
</html> | |||
==About== | ==About== | ||
Line 81: | Line 83: | ||
'''Summary''' | '''Summary''' | ||
'''Notes''' | '''Notes''' | ||
Line 125: | Line 88: | ||
The majority of 2022 will be devoted to the rapid development and production of Reference Designs for Air Purification Units (APU) which will be deployed either as a standalone product of varying volumetric flow rate or integrated into larger air handling systems (HVAC). | The majority of 2022 will be devoted to the rapid development and production of Reference Designs for Air Purification Units (APU) which will be deployed either as a standalone product of varying volumetric flow rate or integrated into larger air handling systems (HVAC). | ||
In the UK, standalone APUs will be manufactured and sold by STL in order to stimulate the market and demonstrate the technology and market opportunity to potential licensees. Production will be outsourced to a contract manufacturer. | In the UK, standalone APUs will be manufactured and sold by STL in order to stimulate the market and demonstrate the technology and market opportunity to potential licensees. Production will be outsourced to a contract manufacturer. | ||
The UK launch of the STL manufactured APU will be in January 2023. This will be followed by licenced APU and HVAC unit licence fee revenues commencing in July 2023. Thereafter, revenues are expected to climb steadily as market share increases and new geographical markets are served. It is expected that revenues for financial year (FY) 22/23 will total £631k and grow to £5.3m in FY23/24 and £14.4m in FY24/25. The majority of expenditure in Q4 FY21/22 and the first half of FY22/23 is devoted to spending on research and development. This is then replaced by marketing and professional fees relating to the promotion and licencing of the reference designs. | The UK launch of the STL manufactured APU will be in January 2023. This will be followed by licenced APU and HVAC unit licence fee revenues commencing in July 2023. Thereafter, revenues are expected to climb steadily as market share increases and new geographical markets are served. It is expected that revenues for financial year (FY) 22/23 will total £631k and grow to £5.3m in FY23/24 and £14.4m in FY24/25. The majority of expenditure in Q4 FY21/22 and the first half of FY22/23 is devoted to spending on research and development. This is then replaced by marketing and professional fees relating to the promotion and licencing of the reference designs. | ||
In terms of profitability, FY21/22 is forecast to have a loss of £27k after tax (including R&D tax credits). Revenue starts flowing in Q4 of FY22/23, but the year is forecast to be loss making with a net loss after tax of £399k. A loss of £173k is incurred in the first 5 months of FY23/24 followed by a profit of £1.2m for the rest of the year giving an overall profit for the year of £984k. A Profit of £5.7m after tax is then forecast for FY24/25. Gross margin increases from 45% in FY23/24 to 59% in FY24/25 reflecting the increasing proportion of high margins implicit in an IP licensing business model. Net margins increase from 19% to 39% over the same period. | In terms of profitability, FY21/22 is forecast to have a loss of £27k after tax (including R&D tax credits). Revenue starts flowing in Q4 of FY22/23, but the year is forecast to be loss making with a net loss after tax of £399k. A loss of £173k is incurred in the first 5 months of FY23/24 followed by a profit of £1.2m for the rest of the year giving an overall profit for the year of £984k. A Profit of £5.7m after tax is then forecast for FY24/25. Gross margin increases from 45% in FY23/24 to 59% in FY24/25 reflecting the increasing proportion of high margins implicit in an IP licensing business model. Net margins increase from 19% to 39% over the same period. | ||
Line 141: | Line 102: | ||
Our planned exit-route is through a trade sale to an established air-purification systems manufacturer. Competition amongst existing players is driving a need for clear differentiation, beyond branding. Through its avoidance of HEPA filters and UV lamps, our technology offers a clear path to differentiation on the grounds of cost, environmental friendliness and ease of maintenance. | Our planned exit-route is through a trade sale to an established air-purification systems manufacturer. Competition amongst existing players is driving a need for clear differentiation, beyond branding. Through its avoidance of HEPA filters and UV lamps, our technology offers a clear path to differentiation on the grounds of cost, environmental friendliness and ease of maintenance. | ||